Live Breaking News & Updates on Biocon biologics limited campus site

Stay updated with breaking news from Biocon biologics limited campus site. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Biocon shares in focus today as US FDA issues four observations for insulin facility

Biocon stock ended 2.05% higher at Rs 276.50 on Thursday against the previous close of Rs 270.95 on BSE. The stock touched an intraday high of Rs 277.60 .

United-states , Biocon-biologics , Drug-administration , Biocon-biologics-limited-campus-site , Biocon , Biocon-ltd , United-states-food , Biocon-biologics-limited , Biocon-campus , Drug-substance , Pre-approval-supplement , Preventive-action

US FDA issues 4 observations for Biocon Biologics' insulin facility

The trigger for this inspection was a Pre-Approval Supplement (PAS) filed by BBL's customer late last year

United-states , Biocon-biologics , Biocon-biologics-limited-campus-site , Drug-administration , United-states-food , Biocon-biologics-limited , Biocon-campus , Drug-substance , Pre-approval-supplement , Preventive-action , Biocon , Ndia